
Akumin AKU
Quartalsbericht 2023-Q3
hinzugefügt 12.12.2023
Akumin Kurshistorie 2011-2026 | AKU
Kurshistorie Jährlich Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.84 | 1.08 | 3.64 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.64 | 0.84 | 1.85 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Brainsway Ltd.
BWAY
|
8.85 | $ 13.77 | 2.0 % | $ 99.4 M | ||
|
Biodesix
BDSX
|
0.71 | $ 15.11 | -2.77 % | $ 1.96 B | ||
|
Biomerica
BMRA
|
3.13 | $ 2.12 | -1.85 % | $ 4.87 M | ||
|
Bioventus
BVS
|
9.12 | $ 9.1 | -0.55 % | $ 606 M | ||
|
DexCom
DXCM
|
65.4 | $ 66.08 | -0.78 % | $ 25.8 B | ||
|
Exact Sciences Corporation
EXAS
|
103 | $ 104.91 | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 16.63 | 1.77 % | $ 503 M | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Guardant Health
GH
|
107 | $ 85.73 | 2.56 % | $ 10.7 B | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
IDEXX Laboratories
IDXX
|
636 | $ 567.23 | -0.52 % | $ 45.6 B | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
103 | $ 123.52 | -1.95 % | $ 19.6 B | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Co-Diagnostics
CODX
|
1.19 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 74.46 | 0.3 % | $ 5.03 B | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
155 | $ 160.34 | 0.72 % | $ 7.95 B | ||
|
IQVIA Holdings
IQV
|
165 | $ 164.13 | -1.18 % | $ 28.2 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 463.73 | 0.65 % | $ 13.4 B | ||
|
Organovo Holdings
ONVO
|
2.12 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
1.96 | - | -16.95 % | $ 1.54 M | ||
|
Mettler-Toledo International
MTD
|
1.38 K | $ 1 256.27 | -0.65 % | $ 25.9 B | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 4.59 | -0.43 % | $ 425 M | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 9.21 | 1.1 % | $ 2 B | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
National Research Corporation
NRC
|
14.1 | $ 16.84 | -3.44 % | $ 377 M | ||
|
Natera
NTRA
|
53.9 | $ 197.84 | 1.71 % | $ 19.5 B | ||
|
Interpace Biosciences
IDXG
|
0.94 | $ 1.71 | - | $ 7.5 M | ||
|
Pacific Biosciences of California
PACB
|
1.66 | $ 1.38 | -0.5 % | $ 414 M | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Precipio
PRPO
|
6.7 | $ 28.01 | 5.3 % | $ 36.4 M | ||
|
Personalis
PSNL
|
4.28 | $ 8.03 | 3.21 % | $ 476 M | ||
|
Celcuity
CELC
|
10.1 | $ 107.79 | 5.66 % | $ 4.25 B | ||
|
RadNet
RDNT
|
74.8 | $ 60.41 | 0.89 % | $ 4.54 B | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 266.64 | 0.2 % | $ 22.2 B | ||
|
ENDRA Life Sciences
NDRA
|
4.1 | $ 3.78 | 11.03 % | $ 2.03 M |